Chromatin/Epigenetics


Epigenetics is the heritable modifications in gene expression that is not associated with changes in DNA sequence. Epigenetic modifications occur mostly on DNA or on the histone octamer. There are several types of epigenetics modifications, DNA methylation by DNA-methyl transferase (DNMT) and covalent modification of histones (e.g. acetylation, methylation, phosphorylation and ubiquitination). Histone acetylation by histone acetyltransferases (HATs) is involved in transcriptional activation, whereas histone deacetylation by histone deacetylases (HDACs) is connected with transcriptional repression. Histone demethylation is associated with lysine-specific demethylase (LSD) and JmjC domain containing histone demethylase (JHDM).
The nucleosome is consisted of four histone proteins (H2A, H2B, H3, and H4), they are primary building block of chromatin. The addition and removal of specific chemical groups refers to as epigenetic marks, it regulates chromatin structure and affects gene expression. Moreover, RNA is intimately involved in the formation of a repressive chromatin state.
Epigenetic mechanism responds to environmental changes at the cellular level and thus influences cellular plasticity. Chromatin and epigenetic regulation play a significant role in the programming of the genome during development and stress response, defects in epigenetics can lead to cancer, inflammation and metabolic disorders etc.
-
A4611 BRD3308Summary: A selective histone deacetylase 3 (HDAC3) inhibitor that protects pancreatic β cells and activates HIV-1 transcription for diabetes and HIV-1 latency -
A4612 Belinostat1 CitationSummary: An HDAC inhibitor for the treatment of peripheral T-cell lymphoma -
A4613 HDAC8-IN-1Summary: A selective HDAC8 inhibitor that modulates epigenetic gene expression -
A4624 PFI-90Summary: A KDM inhibitor that selectively inhibits KDM3B and disrupts PAX3-FOXO1 function for alveolar rhabdomyosarcoma -
A4689 PF-06409577Summary: A selective allosteric AMPK α1β1γ1 isoform activator that regulates metabolic homeostasis -
A4704 KSQ-4279Summary: A small-molecule inhibitor that dually targets USP1 and PARP1 for cancer -
A4723 MetforminSummary: A drug for the treatment of type 2 diabetes and enhancing insulin sensitivity -
A4751 AmarogentinSummary: A secoiridoid glycoside with antitumor, antioxidant, antidiabetic and immunomodulatory activities -
A4753 CPTH2Summary: An inhibitor that selectively inhibits Gcn5- and p300-mediated histone acetylation and induces apoptosis -
A4783 Coenzyme Q0Summary: A quinone compound that induces apoptosis and autophagy and inhibits angiogenesis

